Topic Hub
23 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 23 of 23 clinical reviews.
Does ipamorelin increase or suppress appetite? A physician-reviewed breakdown of the mechanisms, clinical data, and practical dosing considerations for ipamorelin acetate and its effects on hunger and food cravings.
Read clinical reviewA physician-reviewed guide to using ipamorelin acetate in patients with autoimmune conditions: immune modulation mechanisms, safety evidence, contraindications, monitoring protocols, and clinical decision-making frameworks.
Read clinical reviewA physician-reviewed guide to how ipamorelin acetate affects bone mineral density, IGF-1 signaling, osteoblast activity, and fracture risk, with primary-literature citations and clinical dosing context.
Read clinical reviewA physician-level review of ipamorelin acetate and cancer risk, covering IGF-1 biology, preclinical data, clinical evidence gaps, and how to screen patients before prescribing.
Read clinical reviewA physician-reviewed, evidence-based look at how ipamorelin acetate affects the heart and vasculature over months to years, covering GH-axis mechanisms, lipid and endothelial effects, cardiac remodeling data, and clinical monitoring protocols.
Read clinical reviewA clinician-level review of ipamorelin acetate and its effects on cognitive function, covering GH/IGF-1 pathways, neuroprotection research, dosing protocols, and what patients using GH secretagogues can realistically expect.
Read clinical reviewA physician-level review of ipamorelin acetate's clinical evidence, graded using the GRADE framework. Covers selectivity data, human trials, off-label status, and what the evidence actually supports.
Read clinical reviewA physician-reviewed, citation-dense guide to how ipamorelin acetate affects hair growth and skin quality, covering IGF-1 signaling, collagen synthesis, clinical data, dosing, and what to realistically expect.
Read clinical reviewA detailed, physician-reviewed look at how ipamorelin acetate affects liver function, including ALT/AST changes, IGF-1 signaling through hepatocytes, relevant clinical data, and monitoring protocols for patients on GH secretagogue therapy.
Read clinical reviewA physician-reviewed deep dive into how ipamorelin acetate affects mood, cognition, sleep quality, and mental wellbeing, with primary-literature citations and clinical context.
Read clinical reviewHow ipamorelin acetate stimulates GH secretion, accelerates lipolysis, and shifts energy expenditure, with primary-literature citations, dosing guidance, and an updated clinical framework.
Read clinical reviewA physician-reviewed deep-dive into ipamorelin acetate microdosing protocols, covering the clinical pharmacology, dosing evidence from Raun et al. And related trials, practical administration schedules, and safety monitoring for GH secretagogue therapy.
Read clinical reviewA physician-reviewed, evidence-based guide to using ipamorelin acetate for muscle preservation, covering mechanisms, dosing protocols, combination strategies, and primary-literature citations.
Read clinical reviewMD/PharmD-level guide to diagnosing and correcting ipamorelin plateaus: dosing schedules, receptor desensitization, lifestyle confounders, and when to switch strategies.
Read clinical reviewA physician-reviewed guide covering ipamorelin acetate use after bariatric surgery, including GH secretagogue physiology, dosing considerations, risks, and the latest clinical evidence.
Read clinical reviewA physician-reviewed guide covering the ipamorelin acetate pre-surgery hold window, including how long to stop dosing before anesthesia, why GH secretagogues require perioperative planning, and how to restart safely after procedures.
Read clinical reviewA physician-reviewed guide to what happens when you stop ipamorelin, including GH axis rebound, symptom timelines, withdrawal data, and clinical restart protocols from the HealthRX medical team.
Read clinical reviewA physician-level review of ipamorelin acetate and kidney health, covering GH/IGF-1 renal physiology, preclinical protection signals, risk factors for GH-axis hyperfiltration, dosing considerations, and what to monitor before and during use.
Read clinical reviewA physician-reviewed guide to ipamorelin acetate dosing, cycling strategy, and physiological rationale across all four seasons, with primary-literature citations throughout.
Read clinical reviewA clinician-level review of how ipamorelin acetate affects sexual function, libido, and related hormonal axes, with primary-literature citations, real doses, and a decision framework for prescribers.
Read clinical reviewA deep clinical review of how ipamorelin acetate alters sleep architecture, slow-wave sleep, and GH pulse timing. Includes trial data, dosing guidance, and physician-reviewed analysis.
Read clinical reviewA physician-reviewed, week-by-week breakdown of what happens during the first four weeks on ipamorelin acetate, covering sleep, body composition, GH pulse data, and dosing protocols.
Read clinical reviewA physician-reviewed guide to safely restarting ipamorelin acetate after acute illness, covering timing, dose titration, lab monitoring, and contraindications based on primary endocrinology literature.
Read clinical review